Extract from Blood Products Advisory Committee meeting safety and purity of plasma derivatives on July 19, 1983. Discusses different presentations including a presentation by Steven Ojala of Cutter, which explains recalling the product, risks, and availability concerns. States link between blood products and AIDS is inconclusive and that a screening program is recommended to minimise risk.